胆固醇神经元活动通过肌肉信号促进扩散性中线质瘤的生长
Richard Drexler1, Antonia Drinnenberg2, Avishai Gavish3
1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA.
Cell
|June 20, 2025
概括
中脑胆能神经元促进扩散中线质瘤 (DMG) 的生长和寡细胞前体细胞 (OPC) 的增殖. 这种作用依赖于电路,并通过对DMG细胞中的M1/ M3受体起作用的乙胆介导.
科学领域:
- 神经科学
- 癌症学
- 细胞生物学
背景情况:
- 谷氨酸活性会影响寡细胞前体细胞 (OPC) 和质瘤增殖.
- 大脑干神经调节神经元在扩散中线质瘤 (DMG) 发展中的作用尚不清楚.
研究的目的:
- 研究中脑胆固醇神经元活动对OPC和DMG扩散的影响.
- 阐明 cholinergic 投射影响质瘤生长的特定电路机制.
主要方法:
- 特定中脑胆固醇核的光遗传刺激 (PPN,LDT).
- 在体内和体外的DMG共同培养模型.
- 单细胞RNA测序以识别受体表达.
- 对M1/M3受体的药理和遗传阻断.
主要成果:
- 胆基核 (PPN) 刺激促进了核质瘤的生长;后背核 (LDT) 刺激促进了乳头质瘤的生长.
- 携带DMG的小鼠表现出乙胆释放和胆活性的增加.
- 胆神经元在共同培养中增强了DMG增殖,乙胆通过CHRM1和CHRM3受体直接作用于DMG细胞.
- 阻断M1/M3受体消除了胆固醇驱动的DMG扩散.
结论:
- 中脑胆固醇投射以特定电路的方式促进活动依赖的DMG生长.
- 这种机制反映了对健康OPC的增殖效应.
- 针对M1/M3受体可能为DMG提供治疗策略.
相关概念视频
Cholinergic Receptors: Muscarinic
3.3K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
3.3K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.6K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.6K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
854
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
854
Cholinergic Antagonists: Pharmacological Actions
1.3K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.3K
Parasympathetic Signaling
2.2K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
2.2K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
915
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
915


